232 related articles for article (PubMed ID: 38096051)
21. Cell cloning-based transcriptome analysis in Rett patients: relevance to the pathogenesis of Rett syndrome of new human MeCP2 target genes.
Nectoux J; Fichou Y; Rosas-Vargas H; Cagnard N; Bahi-Buisson N; Nusbaum P; Letourneur F; Chelly J; Bienvenu T
J Cell Mol Med; 2010 Jul; 14(7):1962-74. PubMed ID: 20569274
[TBL] [Abstract][Full Text] [Related]
22. Mecp2-null mice provide new neuronal targets for Rett syndrome.
Urdinguio RG; Lopez-Serra L; Lopez-Nieva P; Alaminos M; Diaz-Uriarte R; Fernandez AF; Esteller M
PLoS One; 2008; 3(11):e3669. PubMed ID: 18989361
[TBL] [Abstract][Full Text] [Related]
23. MeCP2 dysfunction in Rett syndrome and related disorders.
Moretti P; Zoghbi HY
Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
[TBL] [Abstract][Full Text] [Related]
24. Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome.
Robinson L; Guy J; McKay L; Brockett E; Spike RC; Selfridge J; De Sousa D; Merusi C; Riedel G; Bird A; Cobb SR
Brain; 2012 Sep; 135(Pt 9):2699-710. PubMed ID: 22525157
[TBL] [Abstract][Full Text] [Related]
25. Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome.
Okabe Y; Takahashi T; Mitsumasu C; Kosai K; Tanaka E; Matsuishi T
PLoS One; 2012; 7(4):e35354. PubMed ID: 22532851
[TBL] [Abstract][Full Text] [Related]
26. A segment of the Mecp2 promoter is sufficient to drive expression in neurons.
Adachi M; Keefer EW; Jones FS
Hum Mol Genet; 2005 Dec; 14(23):3709-22. PubMed ID: 16251199
[TBL] [Abstract][Full Text] [Related]
27. Methyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders.
Bach S; Ryan NM; Guasoni P; Corvin AP; El-Nemr RA; Khan D; Sanfeliu A; Tropea D
Sci Rep; 2020 Dec; 10(1):22255. PubMed ID: 33335218
[TBL] [Abstract][Full Text] [Related]
28. The role of MeCP2 in CNS development and function.
Na ES; Monteggia LM
Horm Behav; 2011 Mar; 59(3):364-8. PubMed ID: 20515694
[TBL] [Abstract][Full Text] [Related]
29. MeCP2-E1 isoform is a dynamically expressed, weakly DNA-bound protein with different protein and DNA interactions compared to MeCP2-E2.
Martínez de Paz A; Khajavi L; Martin H; Claveria-Gimeno R; Tom Dieck S; Cheema MS; Sanchez-Mut JV; Moksa MM; Carles A; Brodie NI; Sheikh TI; Freeman ME; Petrotchenko EV; Borchers CH; Schuman EM; Zytnicki M; Velazquez-Campoy A; Abian O; Hirst M; Esteller M; Vincent JB; Malnou CE; Ausió J
Epigenetics Chromatin; 2019 Oct; 12(1):63. PubMed ID: 31601272
[TBL] [Abstract][Full Text] [Related]
30. Methyl CpG Binding Protein 2 Gene Disruption Augments Tonic Currents of γ-Aminobutyric Acid Receptors in Locus Coeruleus Neurons: IMPACT ON NEURONAL EXCITABILITY AND BREATHING.
Zhong W; Cui N; Jin X; Oginsky MF; Wu Y; Zhang S; Bondy B; Johnson CM; Jiang C
J Biol Chem; 2015 Jul; 290(30):18400-11. PubMed ID: 25979331
[TBL] [Abstract][Full Text] [Related]
31. Astrocyte Transcriptome from the Mecp2(308)-Truncated Mouse Model of Rett Syndrome.
Delépine C; Nectoux J; Letourneur F; Baud V; Chelly J; Billuart P; Bienvenu T
Neuromolecular Med; 2015 Dec; 17(4):353-63. PubMed ID: 26208914
[TBL] [Abstract][Full Text] [Related]
32. Loss of O-GlcNAcylation on MeCP2 at Threonine 203 Leads to Neurodevelopmental Disorders.
Cheng J; Zhao Z; Chen L; Li Y; Du R; Wu Y; Zhu Q; Fan M; Duan X; Wu H
Neurosci Bull; 2022 Feb; 38(2):113-134. PubMed ID: 34773221
[TBL] [Abstract][Full Text] [Related]
33. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes.
Chao HT; Chen H; Samaco RC; Xue M; Chahrour M; Yoo J; Neul JL; Gong S; Lu HC; Heintz N; Ekker M; Rubenstein JL; Noebels JL; Rosenmund C; Zoghbi HY
Nature; 2010 Nov; 468(7321):263-9. PubMed ID: 21068835
[TBL] [Abstract][Full Text] [Related]
34. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
Yang W; Pan H
Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
[TBL] [Abstract][Full Text] [Related]
35. Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons.
Smrt RD; Eaves-Egenes J; Barkho BZ; Santistevan NJ; Zhao C; Aimone JB; Gage FH; Zhao X
Neurobiol Dis; 2007 Jul; 27(1):77-89. PubMed ID: 17532643
[TBL] [Abstract][Full Text] [Related]
36. Rett syndrome: disruption of epigenetic control of postnatal neurological functions.
Pohodich AE; Zoghbi HY
Hum Mol Genet; 2015 Oct; 24(R1):R10-6. PubMed ID: 26060191
[TBL] [Abstract][Full Text] [Related]
37. The molecular pathology of Rett syndrome: synopsis and update.
Akbarian S; Jiang Y; Laforet G
Neuromolecular Med; 2006; 8(4):485-94. PubMed ID: 17028371
[TBL] [Abstract][Full Text] [Related]
38. Loss of MeCP2 in Parvalbumin-and Somatostatin-Expressing Neurons in Mice Leads to Distinct Rett Syndrome-like Phenotypes.
Ito-Ishida A; Ure K; Chen H; Swann JW; Zoghbi HY
Neuron; 2015 Nov; 88(4):651-8. PubMed ID: 26590342
[TBL] [Abstract][Full Text] [Related]
39. MeCP2 links heterochromatin condensates and neurodevelopmental disease.
Li CH; Coffey EL; Dall'Agnese A; Hannett NM; Tang X; Henninger JE; Platt JM; Oksuz O; Zamudio AV; Afeyan LK; Schuijers J; Liu XS; Markoulaki S; Lungjangwa T; LeRoy G; Svoboda DS; Wogram E; Lee TI; Jaenisch R; Young RA
Nature; 2020 Oct; 586(7829):440-444. PubMed ID: 32698189
[TBL] [Abstract][Full Text] [Related]
40. High levels of MeCP2 depress MHC class I expression in neuronal cells.
Miralvès J; Magdeleine E; Kaddoum L; Brun H; Peries S; Joly E
PLoS One; 2007 Dec; 2(12):e1354. PubMed ID: 18159237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
